The role of growth factors in the repair of bone biology and clinical applications

Journal of Bone and Joint Surgery

Volumn 84, Issue 6, 2002, Pages 1032-1044

  Lieberman, Jay R ^a   Daluiski, Aaron ^a   Einhorn, Thomas A ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA;

BONE ATROPHY; BONE REMODELING; CELL SECRETION; CLINICAL FEATURE; DRUG DELIVERY SYSTEM; FRACTURE HEALING; GENE THERAPY; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PSEUDARTHROSIS; REVIEW; SPINE FUSION; TARGET CELL; TISSUE ENGINEERING;

EID: 0036599845     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200206000-00022     Document Type: Review

References (111)

1. Instructional Course Lecture, American Academy of Orthopaedic Surgeons. Growth factors as therapeutic agents
2. Growth factor regulation of fracture repair
3. TGFbeta signaling: Receptors, transducers, and Mad proteins
4. TGF-beta signalling from cell membrane to nucleus through SMAD proteins
5. Signal transduction by bone morphogenetic proteins
6. Bone morphogenetic proteins: An update on basic biology and clinical relevance
7. Human type 11 receptor for bone morphogenic proteins (BMPs): Extension of the two-kinase receptor model to the BMPs
8. Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type 11 receptor during fracture healing in rats
9. Growth factors as therapeutic agents
10. Growth factors for bone growth and repair: IGF, TGF beta and BMP
11. The potential role of transforming growth factor beta in fracture healing
12. Transcriptional control by the TGF-beta/Smad signaling system
13. A human Mad protein acting as a BMP-regulated transcriptional activator
14. Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro
15. Expression of four growth factors during fracture repair
16. Regulation of fracture repair by growth factors
17. Transforming growth factor-beta in the regulation of fracture repair
18. In vivo stimulation of bone formation by transforming growth factor-beta
19. Transforming growth factor-beta enhances fracture healing in rabbit tibiae
20. Local injection of TGF-beta increases the strength of tibial fractures in the rat
21. The effect of exogenous transforming growth factor-beta 2 on healing fractures in the rabbit
22. Enhancement of bone ingrowth by transforming growth factor-beta
23. Fibrodysplasia ossificans progressiva: A clue from the fly?
24. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva
25. Chromosomal assignment of the human gene for bone morphogenetic protein 4
26. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye
27. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning
28. Deficient expression of mRNA for the putative inductive factor bone morphogenetic protein-7 in chemically initiated rat nephroblastomas
29. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF beta super-family
30. Bone: Formation by autoinduction
31. Novel regulators of bone formation: Molecular clones and activities
32. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates
33. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model
34. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats
35. Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model
36. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein
37. Evaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect model
38. Potential role of bone morphogenetic proteins in fracture healing
39. Experimental spinal fusion with recombinant human bone morphogenetic protein-2
40. Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model
41. Evaluation of human bone morphogenetic protein 2 in a canine spinal fusion model
42. Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage
43. Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation
44. Basic fibroblast growth factor for stimulation of bone formation in osteoinductive or conductive implants
45. Molecular mechanisms of angiogenesis fibroblast growth factor signal transduction
46. Growth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor
47. Acidic fibroblast growth factor (aFGF) injection stimulates cartilage enlargement and inhibits cartilage gene expression in rat fracture healing
48. Effects of basic fibroblast growth factor on bone formation in vitro
49. Structural diversity and binding of FGF receptors
50. Fibroblast growth factor receptors (FGFRs) and their roles in limb development
51. Fibroblast growth factor receptor 3 is a negative regulator of bone growth
52. Update on the genetic basis of disorders with orthopaedic manifestations
53. Potential role of fibroblast growth factor in enhancement of fracture healing
54. Single local injection of recombinant fibroblast growth factor-2 stimulates healing of segmental bone defects in rabbits
55. Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture
56. Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates
57. Growth factor treatment of disorders of skeletal growth
58. Potential role of insulinlike growth factors in fracture healing
59. Insulinlike growth factor gene expression in human fracture callus
60. Dose response of growth hormone on fracture healing in the rat
61. Failure of growth hormone to alter the biomechanics of fracture-healing in a rabbit model
62. The effects of insulin-like growth factor-1 on critical-size calvarial defects in Sprague-Dawley rats
63. Platelet-derived growth factor expression in normally healing human fractures
64. Effects of platelet-derived growth factor on bone formation in vitro
65. Effect of platelet-derived growth factor on tibial osteotomies in rabbits
66. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats
67. Calcium sulfate- and calcium phosphate-based bone substitutes. Mimicry of the mineral phase of bone
68. Evaluation of particulate Bioglass in a rabbit radius ostectomy model
69. Use of bone-graft substitutes in distal radius fractures
70. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: A preliminary report
71. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation
72. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation
73. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model
74. Carrier systems for bone morphogenetic proteins
75. Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone
76. Poly(alpha-hydroxy acids): Carriers for bone morphogenetic proteins
77. Synthetic biodegradable polymers for orthopaedic applications
78. Delivery systems for BMPs: Factors contributing to protein retention at an application site
79. Porous hydroxyapatite as a bone-graft substitute in metaphyseal defects. A histometric study
80. Osteogenic potential of allogeneic rat marrow cells in porous hydroxyapatite ceramics: A histological study
81. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects
82. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones
83. Repair of large cortical defects with block coralline hydroxyapatite
84. Composites of bone morphogenetic protein (BMP) and type IV collagen, coral-derived coral hydroxyapatite, and tricalcium phosphate ceramics
85. Morphological and biomechanical difference in healing in segmental tibial defects implanted with Biocoral or tricalcium phosphate cylinders
86. Evaluation of bovine-derived bone protein with a natural coral carrier as a bone-graft substitute in a canine segmental defect model
87. Augmentation of distal radius fracture fixation with coralline hydroxyapatite bone graft substitute
88. Healing of segmental bone defects in rats induced by a beta-TCP-MCPM cement combined with rhBMP-2
89. Development of tricalcium phosphate/amylopectin paste combined with recombinant human transforming growth factor beta 1 as a bone defect filler
90. Porous ceramics as bone graft substitutes in long bone defects: A biomechanical, histological, and radiographic analysis
91. Osteoconductive materials and their role as substitutes for autogenous bone grafts
92. Coralline bone graft substitutes
93. The critical role of geometry of porous hydroxyapatite delivery system in induction of bone by osteogenin, a bone morphogenetic protein
94. Hyaluronic acid-based polymers as cell carriers for tissue-engineered repair of bone and cartilage
95. Stimulation of osteoinduction in bone wound healing by high-molecular hyaluronic acid
96. Possible orthopaedic applications of gene therapy
97. Gene therapy for osteoinduction
98. Transfer of genes to humans: Early lessons and obstacles to success
99. Human gene therapy
100. Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics
101. Genetic enhancement of fracture repair: Healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene
102. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes
103. Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration
104. Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1)
105. Adenoviral delivery of LIM mineralization protein-1 induces new-bone formation in vitro and in vivo
106. Morbidity at bone graft donor sites
107. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect
108. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions
109. The role of growth factors in the healing of chronic wounds